Sabra Health Care REIT, Inc.
For the period ended Mar 31, 2026. Filed Apr 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 29, 2026
SBRA$21.47+2.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
| Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’Equity · Noncontrolling Interests · Total Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amounts | ||||||||
| Balance, December 31, 2024 | 237,586,882 | $2,376 | $4,592,605 | $(1,874,633) | $20,940 | $2,741,288 | $— | $2,741,288 |
| Net income | — | — | — | 40,304 | — | 40,304 | — | 40,304 |
| Other comprehensive loss | — | — | — | — | (5,728) | (5,728) | — | (5,728) |
| Amortization of stock-based compensation | — | — | 4,275 | — | — | 4,275 | — | 4,275 |
| Common stock issuance, net | 349,578 | 3 | (4,973) | — | — | (4,970) | — | (4,970) |
| Common dividends ($0.30 per share) | — | — | — | (72,937) | — | (72,937) | — | (72,937) |
| Balance, March 31, 2025 | 237,936,460 | $2,379 | $4,591,907 | $(1,907,266) | $15,212 | $2,702,232 | $— | $2,702,232 |
| Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’Equity · Noncontrolling Interests · Total Equity | ||||||||
| Shares · Amounts | ||||||||
| Balance, December 31, 2025 | 251,697,456 | $2,517 | $4,836,270 | $(2,013,375) | $(3,571) | $2,821,841 | $1,947 | $2,823,788 |
| Net income (loss) | — | — | — | 40,880 | — | 40,880 | (67) | 40,813 |
| Other comprehensive income | — | — | — | — | 4,262 | 4,262 | — | 4,262 |
| Amortization of stock-based compensation | — | — | 4,789 | — | — | 4,789 | — | 4,789 |
| Common stock issuance, net | 492,639 | 5 | (8,395) | — | — | (8,390) | — | (8,390) |
| Common dividends ($0.30 per share) | — | — | — | (77,348) | — | (77,348) | — | (77,348) |
| Balance, March 31, 2026 | 252,190,095 | $2,522 | $4,832,664 | $(2,049,843) | $691 | $2,786,034 | $1,880 | $2,787,914 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.